Alimera Sciences, Inc. (ALIM)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
1.30+0.02 (+1.56%)
At close: 4:00 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close1.28
Bid1.16 x 300
Ask1.53 x 1100
Day's Range1.26 - 1.38
52wk Range1.01 - 5.15
1y Target EstN/A
Market Cap84.2M
P/E Ratio (ttm)-1.92
Avg Vol (3m)895,189
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • GlobeNewswire17 hours ago

    Alimera Sciences Begins Selling ILUVIEN® in the Middle East

    ATLANTA, Oct. 26, 2016-- Alimera Sciences, Inc., a leader in research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that its subsidiary, Alimera Sciences ...

  • GlobeNewswire6 days ago

    Alimera Sciences Strengthens Financial Position

    Facility increased to $45 million. Interest only repayment period extended up to 18 months. ATLANTA, Oct. 20, 2016-- Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development ...

  • Capital Cube7 days ago

    ETF’s with exposure to Alimera Sciences, Inc. : October 20, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Alimera Sciences, Inc. Here are 5 ETF’s with the largest exposure to ALIM-US. Comparing the performance and risk of Alimera Sciences, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)